Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11550608 | 0.87 | POLB (0.32) | POLBTSHRSLC1A2MEN1CYP1A2 | |
| SCHEMBL4594903 | 0.80 | TRPA1 (0.33) | — | |
| SCHEMBL29145813 | 0.80 | TRPA1 (0.33) | — | |
| SCHEMBL2349957 | 0.77 | SLC1A2 (0.31) | SLC1A2MEN1CYP1A2ALOX15KMT2A | |
| SCHEMBL4594908 | 0.77 | — | — | |
| SCHEMBL2354559 | 0.75 | POLB (0.30) | POLBTSHRSLC1A2MEN1CYP1A2 | |
| SCHEMBL18105684 | 0.74 | APLNR (0.38) | POLBTSHRSLC1A2MEN1CYP1A2 | |
| SCHEMBL18105681 | 0.74 | APLNR (0.38) | POLBTSHRSLC1A2MEN1CYP1A2 | |
| SCHEMBL7264701 | 0.72 | SLC22A6 (0.32) | POLB | |
| SCHEMBL11665889 | 0.71 | FFAR3 (0.43) | POLBTSHRSLC1A2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2533760-A1 | LIQUID COMPOSITION COMPRISING A NON-MENTHOL COOLING AGENT AND A THICKENER FOR TREATING A RESPIRATORY SYMPTOM | The Procter & Gamble Company (US) | 2012-12-19 | — | — | EP | claimed |
| WO-2011100267-A1 | LIQUID COMPOSITION COMPRISING A NON-MENTHOL COOLING AGENT AND A THICKENER FOR TREATING A RESPIRATORY SYMPTOM | THE PROCTER & GAMBLE COMPANY (US) | 2011-08-18 | — | — | WO | claimed |
| US-20110195042-A1 | Compositions, Methods and Kits Useful for Treating a Respiratory Symptom | THE PROCTER & GAMBLE COMPANY | 2011-08-11 | — | — | US | claimed |
| WO-2007126686-A2 | ABSORBENT ARTICLES WITH FEEDBACK SIGNAL UPON URINATION | THE PROCTER & GAMBLE COMPANY (US) | 2007-11-08 | — | — | WO | claimed |
| US-20070233026-A1 | Absorbent articles with feedback signal upon urination | THE PROCTER & GAMBLE COMPANY | 2007-10-04 | — | — | US | claimed |
| US-12595486-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-04-07 | — | — | US | disclosed |
| US-12584137-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-24 | — | — | US | disclosed |
| US-12584136-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-24 | — | — | US | disclosed |
| US-12584135-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-24 | — | — | US | disclosed |
| US-12359205-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-15 | — | — | US | disclosed |
| CN-119095581-A | Unit dose oral care compositions comprising fluoride | 宝洁公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-113365598-B | Container for personal health compositions | 宝洁公司 | 2024-08-30 | — | — | CN | disclosed |
| US-20120172831-A1 | Methods of Delivering a Health Care Active by Administering Personal Health Care Articles Comprising a Filament | THE PROCTER & GAMBLE COMPANY | 2012-07-05 | — | — | US | disclosed |
| WO-2012003350-A1 | METHODS OF DELIVERING A HEALTH CARE ACTIVE BY ADMINISTERING PERSONAL HEALTH CARE ARTICLES COMPRISING A FILAMENT | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-05 | — | — | WO | disclosed |
| WO-2012003365-A1 | FILAMENTS COMPRISING AN INGESTIBLE ACTIVE AGENT NONWOVEN WEBS AND METHODS FOR MAKING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-05 | — | — | WO | disclosed |
| US-20110195042-A1 | Compositions, Methods and Kits Useful for Treating a Respiratory Symptom | THE PROCTER & GAMBLE COMPANY | 2011-08-11 | — | — | US | disclosed |
| US-20090155189-A1 | Preparations, Methods and Kits Useful for the Treatment of Cough | THE PROCTER & GAMBLE COMPANY (US) | 2009-06-18 | — | — | US | disclosed |
| US-20090130199-A1 | Preparations, Methods And Kits Useful For The Treatment of Cough | THE PROCTER & GAMBLE COMPANY (US) | 2009-05-21 | — | — | US | disclosed |
| US-20070287971-A1 | Absorbent articles with feedback signal upon urination | THE PROCTER & GAMBLE COMPANY | 2007-12-13 | — | — | US | disclosed |
| US-20070233026-A1 | Absorbent articles with feedback signal upon urination | THE PROCTER & GAMBLE COMPANY | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195042-A1 | Compositions, Methods and Kits Useful for Treating a Respiratory Symptom | MUC1, TAS2R42, TAS2R7 | POLB 818/4885TSHR 4034/4885SLC1A2 4002/4885 |
| US-12584136-B2 | Aptamers for personal health care applications | HAVCR2, LDLR, ICAM1 | POLB 1774/4885TSHR 459/4885SLC1A2 3817/4885 |
| US-20090155189-A1 | Preparations, Methods and Kits Useful for the Treatment of Cough | CCL11, CHRM3, CFTR | POLB 1001/4885TSHR 3368/4885SLC1A2 3093/4885 |
| US-12584135-B2 | Aptamers for personal health care applications | ICAM1, VCAM1, EPCAM | POLB 2625/4885TSHR 147/4885SLC1A2 3763/4885 |
| US-12595486-B2 | Aptamers for personal health care applications | HAVCR2, EPCAM, ICAM1 | POLB 2957/4885TSHR 301/4885SLC1A2 3953/4885 |
| US-12584137-B2 | Aptamers for personal health care applications | HAVCR2, LDLR, ICAM1 | POLB 2990/4885TSHR 253/4885SLC1A2 3486/4885 |
| US-20090130199-A1 | Preparations, Methods And Kits Useful For The Treatment of Cough | CCL11, HRH2, CRH | POLB 2373/4885TSHR 1695/4885SLC1A2 3315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.